Professional Financial Advisors LLC Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Professional Financial Advisors LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,238 shares of the healthcare conglomerate’s stock after selling 290 shares during the quarter. Professional Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,141,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of UNH. MCF Advisors LLC acquired a new position in UnitedHealth Group in the first quarter valued at $907,000. Wilbanks Smith & Thomas Asset Management LLC raised its holdings in shares of UnitedHealth Group by 0.4% during the first quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 28,735 shares of the healthcare conglomerate’s stock worth $14,357,000 after purchasing an additional 117 shares during the period. Financial Architects Inc raised its stake in shares of UnitedHealth Group by 5.9% during the first quarter. Financial Architects Inc now owns 1,036 shares of the healthcare conglomerate’s stock valued at $528,000 after purchasing an additional 58 shares in the last quarter. UNIVEST FINANCIAL Corp raised its holdings in shares of UnitedHealth Group by 645.5% in the 1st quarter. UNIVEST FINANCIAL Corp now owns 9,572 shares of the healthcare conglomerate’s stock worth $4,881,000 after purchasing an additional 8,288 shares in the last quarter. Finally, Savant Capital LLC boosted its holdings in shares of UnitedHealth Group by 3.1% in the first quarter. Savant Capital LLC now owns 9,902 shares of the healthcare conglomerate’s stock worth $5,050,000 after buying an additional 297 shares during the period. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now directly owns 76,559 shares in the company, valued at $40,415,496.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Frederick William Mcnabb III acquired 89 shares of the company’s stock in a transaction on Thursday, May 26th. The shares were acquired at an average cost of $504.32 per share, for a total transaction of $44,884.48. Following the purchase, the director now owns 11,259 shares in the company, valued at $5,678,138.88. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders sold a total of 17,649 shares of company stock valued at $9,071,142 over the last quarter. 0.40% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 0.9 %

NYSE:UNH traded up $4.64 during trading hours on Thursday, hitting $539.25. 38,888 shares of the stock traded hands, compared to its average volume of 3,384,512. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60. The firm has a market cap of $505.91 billion, a price-to-earnings ratio of 27.92, a PEG ratio of 1.64 and a beta of 0.77. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The firm has a 50 day moving average price of $500.41 and a 200 day moving average price of $496.04.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter in the prior year, the business earned $4.70 EPS. The business’s revenue for the quarter was up 12.6% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.84 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were given a dividend of $1.65 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date was Thursday, June 16th. This represents a $6.60 annualized dividend and a yield of 1.22%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. Barclays increased their target price on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research note on Wednesday, March 30th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. SVB Leerink increased their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Argus boosted their target price on shares of UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a research report on Monday. Finally, BMO Capital Markets boosted their price objective on shares of UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Three equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $582.50.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.